BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15626485)

  • 1. Induction of CD95 upregulation does not render chronic lymphocytic leukemia B-cells susceptible to CD95-mediated apoptosis.
    Romano C; De Fanis U; Sellitto A; Chiurazzi F; Guastafierro S; Giunta R; Tirelli A; Rotoli B; Lucivero G
    Immunol Lett; 2005 Feb; 97(1):131-9. PubMed ID: 15626485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
    De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
    Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.
    Kater AP; Evers LM; Remmerswaal EB; Jaspers A; Oosterwijk MF; van Lier RA; van Oers MH; Eldering E
    Br J Haematol; 2004 Nov; 127(4):404-15. PubMed ID: 15521917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
    Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
    Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interleukin-2 on CD95 (Fas/APO-1) expression in fresh chronic lymphocytic leukaemia and mantle cell lymphoma cells: relationship to ex vivo chemoresponse.
    Bosanquet AG; Bell PB; Rooney N
    Anticancer Res; 1999; 19(6B):5329-34. PubMed ID: 10697557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.
    McWhirter JR; Kretz-Rommel A; Saven A; Maruyama T; Potter KN; Mockridge CI; Ravey EP; Qin F; Bowdish KS
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1041-6. PubMed ID: 16418292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
    J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
    Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-beta-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells.
    Takada E; Shimo K; Hata K; Abiake M; Mukai Y; Moriyama M; Heasley L; Mizuguchi J
    Exp Cell Res; 2005 Apr; 304(2):518-30. PubMed ID: 15748896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
    Büssing A; Stein GM; Stumpf C; Schietzel M
    Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL.
    Kokhaei P; Choudhury A; Mahdian R; Lundin J; Moshfegh A; Osterborg A; Mellstedt H
    Leukemia; 2004 Nov; 18(11):1810-5. PubMed ID: 15385926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular IFN-gamma expression by CD3+/CD8+ cell subset in B-CLL patients correlates with stage of the disease.
    Podhorecka M; Dmoszynska A; Rolinski J
    Eur J Haematol; 2004 Jul; 73(1):29-35. PubMed ID: 15182335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
    Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
    Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B; Wooldridge JE; Blackwell SE; Taylor CM; Griffith TS; Link BK; Weiner GJ
    J Leukoc Biol; 2005 Mar; 77(3):378-87. PubMed ID: 15582984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apoptosis in chronic lymphocytic leukemia].
    Giordano M
    Medicina (B Aires); 2000; 60 Suppl 2():12-6. PubMed ID: 11188924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD154 gene therapy for human B-cell malignancies.
    Messmer D; Kipps TJ
    Ann N Y Acad Sci; 2005 Dec; 1062():51-60. PubMed ID: 16461788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
    Spaner DE; Hammond C; Mena J; Shi Y
    Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.